Page last updated: 2024-09-03

t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and gramicidin a

t-butyloxycarbonyl-methionyl-leucyl-phenylalanine has been researched along with gramicidin a in 1 studies

Compound Research Comparison

Studies
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Trials
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Recent Studies (post-2010)
(t-butyloxycarbonyl-methionyl-leucyl-phenylalanine)
Studies
(gramicidin a)
Trials
(gramicidin a)
Recent Studies (post-2010) (gramicidin a)
22042,73731334

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacob, J1

Other Studies

1 other study(ies) available for t-butyloxycarbonyl-methionyl-leucyl-phenylalanine and gramicidin a

ArticleYear
Linear gramicidin activates neutrophil functions and the activation is blocked by chemotactic peptide receptor antagonist.
    FEBS letters, 1988, Apr-11, Volume: 231, Issue:1

    Topics: Animals; Chlortetracycline; Gramicidin; Kinetics; Lysosomes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Rabbits; Receptors, Formyl Peptide; Receptors, Immunologic; Spectrometry, Fluorescence; Superoxides

1988